These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26641645)

  • 21. Clinical management of polycystic liver disease.
    van Aerts RMM; van de Laarschot LFM; Banales JM; Drenth JPH
    J Hepatol; 2018 Apr; 68(4):827-837. PubMed ID: 29175241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of MRI segmentation techniques for measuring liver cyst volumes in autosomal dominant polycystic kidney disease.
    Farooq Z; Behzadi AH; Blumenfeld JD; Zhao Y; Prince MR
    Clin Imaging; 2018; 47():41-46. PubMed ID: 28846875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical profile of autosomal dominant polycystic liver disease.
    Qian Q; Li A; King BF; Kamath PS; Lager DJ; Huston J; Shub C; Davila S; Somlo S; Torres VE
    Hepatology; 2003 Jan; 37(1):164-71. PubMed ID: 12500201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adult polycystic liver and kidney diseases are separate entities.
    Karhunen PJ; Tenhu M
    Clin Genet; 1986 Jul; 30(1):29-37. PubMed ID: 3757294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of polycystic liver disease. Update on the management.
    Aussilhou B; Dokmak S; Dondero F; Joly D; Durand F; Soubrane O; Belghiti J
    J Visc Surg; 2018 Dec; 155(6):471-481. PubMed ID: 30145049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease.
    Sherstha R; McKinley C; Russ P; Scherzinger A; Bronner T; Showalter R; Everson GT
    Hepatology; 1997 Nov; 26(5):1282-6. PubMed ID: 9362373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spleen phenotype in autosomal dominant polycystic kidney disease.
    Yin X; Prince WK; Blumenfeld JD; Zhang W; Donahue S; Bobb WO; Rennert H; Askin G; Barash I; Prince MR
    Clin Radiol; 2019 Dec; 74(12):975.e17-975.e24. PubMed ID: 31563290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic venous outflow obstruction in patients with polycystic liver disease: pathogenesis and treatment.
    Uddin W; Ramage JK; Portmann B; Wilson P; Benjamin I; Tan KC; Williams R
    Gut; 1995 Jan; 36(1):142-5. PubMed ID: 7890219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases.
    Abu-Wasel B; Walsh C; Keough V; Molinari M
    World J Gastroenterol; 2013 Sep; 19(35):5775-86. PubMed ID: 24124322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes and Durability of Hepatic Reduction after Combined Partial Hepatectomy and Cyst Fenestration for Massive Polycystic Liver Disease.
    Chebib FT; Harmon A; Irazabal Mira MV; Jung YS; Edwards ME; Hogan MC; Kamath PS; Torres VE; Nagorney DM
    J Am Coll Surg; 2016 Jul; 223(1):118-126.e1. PubMed ID: 27016902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autosomal Dominant Polycystic Kidney Disease in which the Polycystic Liver Volume Was Reduced by Rigorous Blood Pressure Control.
    Suwabe T; Ubara Y; Ikuma D; Mizuno H; Hayami N; Yamanouchi M; Sawa N
    Intern Med; 2022 Jan; 61(1):49-52. PubMed ID: 34219109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevalence of seminal vesicle cysts in autosomal dominant polycystic kidney disease.
    Danaci M; Akpolat T; Baştemir M; Sarikaya S; Akan H; Selçuk MB; Cengiz K
    Nephrol Dial Transplant; 1998 Nov; 13(11):2825-8. PubMed ID: 9829485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Rare Case of Pelvic Organ Prolapse in a Nulliparous Female With Autosomal Dominant Polycystic Kidney Disease (ADPKD) and Polycystic Liver Disease (PLD).
    Hechter S; Ganta N; Kochhar S; Kanukuntla A; Kata P; Turro J; Cheriyath P
    Cureus; 2021 Nov; 13(11):e20023. PubMed ID: 34987911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and Validation of a Disease-Specific Questionnaire to Assess Patient-Reported Symptoms in Polycystic Liver Disease.
    Neijenhuis MK; Gevers TJ; Hogan MC; Kamath PS; Wijnands TF; van den Ouweland RC; Edwards ME; Sloan JA; Kievit W; Drenth JP
    Hepatology; 2016 Jul; 64(1):151-60. PubMed ID: 26970415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obstructive jaundice in a patient with polycystic liver disease complicated with polycystic kidney and polycystic lung: A case report.
    Zhang L; Gan L; Liu Q; Li Y; Lin J; Ou S
    Medicine (Baltimore); 2020 Apr; 99(14):e19511. PubMed ID: 32243367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of liver volume on polycystic liver disease-related symptoms and quality of life.
    Neijenhuis MK; Kievit W; Verheesen SM; D'Agnolo HM; Gevers TJ; Drenth JP
    United European Gastroenterol J; 2018 Feb; 6(1):81-88. PubMed ID: 29435317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Giant hepatic cyst in a patient with ADPKD].
    Pisani A; Riccio E; Imbriaco M; Capuano I; Rossano R; Santangelo M
    G Ital Nefrol; 2012; 29(6):716-9. PubMed ID: 23229669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcatheter arterial embolization therapy for a massive polycystic liver in autosomal dominant polycystic kidney disease patients.
    Park HC; Kim CW; Ro H; Moon JY; Oh KH; Kim Y; Lee JS; Yin YH; Jae HJ; Chung JW; Ahn C; Hwang YH
    J Korean Med Sci; 2009 Feb; 24(1):57-61. PubMed ID: 19270814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacterial Cholangitis in Autosomal Dominant Polycystic Kidney and Liver Disease.
    Martin WP; Vaughan LE; Yoshida K; Takahashi N; Edwards ME; Metzger A; Senum SR; Masyuk TV; LaRusso NF; Griffin MD; El-Zoghby Z; Harris PC; Kremers WK; Nagorney DM; Kamath PS; Torres VE; Hogan MC
    Mayo Clin Proc Innov Qual Outcomes; 2019 Jun; 3(2):149-159. PubMed ID: 31193902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen-Containing Oral Contraceptives Are Associated With Polycystic Liver Disease Severity in Premenopausal Patients.
    van Aerts RMM; Bernts LHP; Gevers TJG; Kievit W; Koopmans L; Nieboer TE; Nevens F; Drenth JPH
    Clin Pharmacol Ther; 2019 Dec; 106(6):1338-1345. PubMed ID: 31206615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.